Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

99
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
99
Antimicrobial Proteins01:23

Antimicrobial Proteins

1.1K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
1.1K
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

144
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
144
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.2K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

51
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
51
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

146
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
146

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Risk Factors of Pressure Injuries in Norwegian Intensive Care Units: A Secondary Analysis.

Acta anaesthesiologica Scandinavica·2026
Same author

Genomic characterization of ceftazidime/avibactam-resistant KPC-producing <i>Klebsiella pneumoniae</i> in bloodstream infections indicates OmpK35 and OmpK36 as pivotal key players in resistance mechanisms.

Frontiers in microbiology·2026
Same author

A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock.

The Journal of antimicrobial chemotherapy·2026
Same author

The impact of an ex vivo paediatric renal replacement therapy circuit on antimicrobial concentrations.

The Journal of antimicrobial chemotherapy·2026
Same author

Ethics essentials: A new article type in ICCN.

Intensive & critical care nursing·2026
Same author

Therapeutic drug monitoring and the role of pharmacokinetics/pharmacodynamics in optimizing beta-lactam antibiotic dosing for deep-seated infections: a systematic review.

The Journal of antimicrobial chemotherapy·2026

Related Experiment Video

Updated: Aug 1, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.4K

Novel Antimicrobial Agents for Gram-Negative Pathogens.

Marios Karvouniaris1, Maria Panagiota Almyroudi2, Mohd Hafiz Abdul-Aziz3

  • 1Intensive Care Unit, AHEPA University Hospital, 546 36 Thessaloniki, Greece.

Antibiotics (Basel, Switzerland)
|April 28, 2023
PubMed
Summary
This summary is machine-generated.

Novel antimicrobials combat rising Gram-negative bacterial resistance. This review details new and investigational drugs like cefiderocol and aztreonam-avibactam, crucial for hospital antimicrobial stewardship.

Keywords:
Acinetobacter baumanniiEnterobacteralesGram-negativePseudomonas aeruginosabeta-lactamasecarbapenemasespharmacodynamicspharmacokinetics

More Related Videos

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

10.5K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.8K

Related Experiment Videos

Last Updated: Aug 1, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.4K
Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

10.5K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.8K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Gram-negative bacterial resistance to antimicrobials is a significant global health challenge.
  • This resistance poses a daily threat to hospital practices and patient outcomes.
  • Existing treatments are becoming less effective due to evolving resistance mechanisms.

Purpose of the Study:

  • To critically review novel antimicrobial agents targeting Gram-negative bacteria.
  • To discuss the characteristics, pharmacokinetics, pharmacodynamics, and clinical data of these emerging drugs.
  • To provide an overview of both recently approved and late-stage investigational antimicrobials.

Main Methods:

  • Literature review of scientific publications and clinical trial data.
  • Critical analysis of pharmacokinetic and pharmacodynamic properties.
  • Evaluation of current clinical evidence for efficacy and safety.

Main Results:

  • Several new antimicrobials (e.g., cefiderocol, imipenem-cilastatin-relebactam) are now available.
  • Multiple agents (e.g., aztreonam-avibactam, sulopenem) are in advanced clinical development (Phase 3).
  • These agents exhibit promising activity against resistant Gram-negative pathogens.

Conclusions:

  • New antimicrobial agents offer vital options against challenging Gram-negative infections.
  • Understanding their properties is essential for effective clinical application and antimicrobial stewardship.
  • Continued research and development are critical to address the growing threat of antimicrobial resistance.